MeSH Review:
Thyroid Neoplasms
Efisio Puxeddu,
Sebastiano Filetti,
Diego Russo,
Nicola Avenia,
Cosimo Durante,
Electron Kebebew,
Boris Bastian,
Orlo H. Clark,
Quan-Yang Duh,
Juergen Bauer,
Julie Weng,
Ann Griffin,
Gustavo Ranvier,
Daniel Shibru,
Czyz,
Balcerczak,
Rudowicz,
Pasieka,
Mirowski,
Niewiadomska,
Kuzdak,
Husmark,
Heldin,
Nilsson,
- Type II amiodarone-induced thyrotoxicosis and concomitant papillary cancer of the thyroid. Cattaneo, F. Eur. J. Endocrinol. (2000)
- Expression of C-ERBB2 and P65 genes and their protein products in follicular neoplasms of thyroid gland. Czyz, W., Balcerczak, E., Rudowicz, M., Niewiadomska, H., Pasieka, Z., Kuzdak, K., Mirowski, M. Folia Histochem. Cytobiol. (2003)
- N-cadherin-mediated adhesion and aberrant catenin expression in anaplastic thyroid-carcinoma cell lines. Husmark, J., Heldin, N.E., Nilsson, M. Int. J. Cancer (1999)
- Somatostatin receptor expression in Hürthle cell cancer of the thyroid. Gulec, S.A., Serafini, A.N., Sridhar, K.S., Peker, K.R., Gupta, A., Goodwin, W.J., Sfakianakis, G.N., Moffat, F.L. J. Nucl. Med. (1998)
- Functional retinoid and thyroid hormone receptors in human thyroid-carcinoma cell lines and tissues. schmutzler, C., Brtko, J., Winzer, R., Jakobs, T.C., Meissner-Weigl, J., Simon, D., Goretzki, P.E., Köhrle, J. Int. J. Cancer (1998)
- Introduction of p53 induces cell-cycle arrest in p53-deficient human medullary-thyroid-carcinoma cells. Velasco, J.A., Medina, D.L., Romero, J., Mato, M.E., Santisteban, P. Int. J. Cancer (1997)
- Detection of thyroid tumour using a monoclonal 123I anti-human thyroglobulin antibody. Shepherd, P.S., Lazarus, C.R., Mistry, R.D., Maisey, M.N. European journal of nuclear medicine. (1985)
- Altered gene expression profiles by sodium/iodide symporter gene transfection in a human anaplastic thyroid carcinoma cell line using a radioactive complementary DNA microarray. Gol Choe, J., Kim, Y.R., Kim, K.N., Choo, H.J., Shin, J.H., Lee, Y.J., Chung, J.K., Kim, M.K. Nuclear medicine communications. (2005)
- Regulation of uptake of 18F-FDG by a follicular human thyroid cancer cell line with mutation-activated K-ras. Prante, O., Maschauer, S., Fremont, V., Reinfelder, J., Stoehr, R., Szkudlinski, M., Weintraub, B., Hartmann, A., Kuwert, T. J. Nucl. Med. (2009)
- Lack of therapeutic effect of the histone deacetylase inhibitor vorinostat in patients with metastatic radioiodine-refractory thyroid carcinoma. Woyach, J.A., Kloos, R.T., Ringel, M.D., Arbogast, D., Collamore, M., Zwiebel, J.A., Grever, M., Villalona-Calero, M., Shah, M.H. J. Clin. Endocrinol. Metab. (2009)
- SKI-606, an Src Inhibitor, Reduces Tumor Growth, Invasion, and Distant Metastasis in a Mouse Model of Thyroid Cancer. Kim, W.G., Guigon, C.J., Fozzatti, L., Park, J.W., Lu, C., Willingham, M.C., Cheng, S.Y. Clin. Cancer Res. (2012)
- Bexarotene via CBP/p300 Induces Suppression of NF-κB-Dependent Cell Growth and Invasion in Thyroid Cancer. Cras, A., Politis, B., Balitrand, N., Darsin-Bettinger, D., Boelle, P.Y., Cassinat, B., Toubert, M.E., Chomienne, C. Clin. Cancer Res. (2012)
- Plasma somatostatin activity in medullary cancer of the thyroid. Neradilová, M., Nĕmec, J., Zamrazil, V., Bednár, J., Pechová, M., Soutorová, M. Oncology (1989)
- Microsurgical neck dissection for metastasizing medullary thyroid carcinoma. Buhr, H.J., Kallinowski, F., Raue, F., Frank-Raue, K., Herfarth, C. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. (1995)
- New serum markers for small-cell lung cancer. II. The neural cell adhesion molecule, NCAM. Vangsted, A., Drivsholm, L., Andersen, E., Bock, E. Cancer Detect. Prev. (1994)
- Increased incidence of thyroid cancer in patients with primary hyperparathyroidism: a continuing dilemma. Fedorak, I.J., Salti, G., Fulton, N., Schark, C., Straus, F.H., Kaplan, E.L. The American surgeon. (1994)
- Thyroid carcinoma as first manifestation of familial adenomatous polyposis. Stigt, J.A., Vasen, H.F., van der Linde, K., van Vliet, A.C. The Netherlands journal of medicine. (1996)
- The prevalence and prognostic value of BRAF mutation in thyroid cancer. Kebebew, E., Weng, J., Bauer, J., Ranvier, G., Clark, O.H., Duh, Q.Y., Shibru, D., Bastian, B., Griffin, A. Ann. Surg. (2007)
- Clinical implications of BRAF mutation in thyroid carcinoma. Puxeddu, E., Durante, C., Avenia, N., Filetti, S., Russo, D. Trends Endocrinol. Metab. (2008)